BridgeMD
Tests treatment safety and results for Caregiver Burden
Official title Evaluating the Efficacy of the Pain Identification and Communication Toolkit
ClinicalTrials.gov ID: NCT06168604
What this study is testing
- What it's testing
- This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with Alzheimer's disease and related dementias (ADRD). PICT provides training in observational pain assessment and coaching in effective pain communication techniques.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- CAREGIVER PARTICIPANTS
- Age 21 or older
- Any gender
- English speaking
- Cognitively intact (BOMC ≤10)
You likely can't join if
- Paid caregiver
- Age 20 or younger
- Non-English speaking
- Cognitively impaired
- Does not provide care to a person with dementia or cognitive impairment who also has a pain diagnosis
- Currently enrolled in hospice
See the full eligibility criteria
- CAREGIVER PARTICIPANTS
- Age 21 or older
- Any gender
- English speaking
- Cognitively intact (BOMC ≤10)
- Provides care to a community-dwelling adult with dementia or cognitive impairment who also has a pain diagnosis
- Care recipient is not enrolled in hospice
- Visits the care recipient at least weekly
- Accessible by telephone
- Paid caregiver
- Age 20 or younger
- Non-English speaking
- Cognitively impaired
- Does not provide care to a person with dementia or cognitive impairment who also has a pain diagnosis
- Currently enrolled in hospice
- The patient to whom the caregiver provides assistance is enrolled in hospice
- Visits care recipient less than weekly
- Not accessible by telephone. PATIENT PARTICIPANTS Inclusion Criteria:
- Residing in community settings
- Record of dementia or cognitive impairment
- Diagnosis of pain
- Responsive to environment
- No terminal illness with life expectancy \<6 months
- Not in active cancer treatment Exclusion Criteria:
- Lives in a residential facility (such as a nursing home or assisted living)
- Enrolled in hospice
- No dementia or cognitive impairment
- Unresponsive to environment
- Has terminal illness with life expectancy \<6 months
- Are in active cancer treatment
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.